PTL Enterprises Ltd.
Snapshot View

50.40 -1.20 ▼-2.3%

05 August 2021, 04:00:00 P.M.
Volume: 18,538

Overview View Details

Sector Miscellaneous Compare with Sector peers
Industry Miscellaneous Compare with Industry peers
Website http://www.ptlenterprise.com
Financial Indicators
Market Cap 333.59 Cr.
Earnings per share (EPS) 5.39 Trailing Twelve Months Ending 2021-06
Price-Earning Ratio (PE) 9.35 Trailing Twelve Months Ending 2021-06
Industry PE 114.86 Trailing Twelve Months Ending 2021-06
Book Value / Share 46.73 Trailing Twelve Months Ending 2021-06
Price to Book Value 1.08 Calculated using Price: 50.40
Dividend Yield 9.92 Period Ending 2021-03
No. of Shares Subscribed 6.62 Cr. 66,188,500 Shares
FaceValue 2
Company Profile

PTL Enterprises was incorporated in the year 1959. The group's principal activity is to manufacture tyres.

The company operates in three segments; namely lease of plant, health care and other corporation. The company plant is located Kalamassery, Alwaye, Kerala 683104. It has given the plant on lease to Apollo Tyres, which manufactures truck and bus tyres sold under brand name ‘Apollo’.

PTL Enterprises manages subsidiaries viz. Artemis Health Sciences Private Limited, Artemis Medicare Services Private Limited, Artemis Life Sciences Private Limited, Artemis Mediequipments Private Limited and Artemis Medical Institute & Hospitals Private Limited.

It subsidiary Artemis Medicare Services Private Limited has set up Artemis Health Institute (AHI) a state-of-the-art, super-speciality hospital in Gurgaon. It is a tertiary care hospital with super-specialisation in oncology (cancer), cardiology, cardiovascular surgery, orthopaedics and minimally invasive surgery and offers high-end care in all other areas of medicine. It is one of the country's technologically most advanced hospitals and houses state-of-the-art imaging equipment including PET-CT Fusion Imaging, 64 Slice CT Angiography and IGRT Machine for all the specialties.

Artemis Health Institute has been awarded the 'Best IT enabled hospital' award for the year 2008.

The subsidiary company is exploring various possibilities in R&D business and partnership with the government for better healthcare.

Its registered office is located at 6th floor, Cherupushpam building, Shanmugham Road, Kochi 682031 (Kerala).

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-2.33%
1 Week
-4.73%
1 Month
-3.08%
3 Month
+32.28%
6 Month
+14.68%
1 Year
+27.92%
2 Year
+53.19%
5 Year
-57.59%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 25.28 23.09 17.75 25.13 24.77 28.88 21.51 25.42 30.93
Return on Capital Employed (%) 26.01 25.00 22.53 35.27 40.59 42.04 32.48 34.79 36.95
Return on Assets (%) 6.82 6.58 5.31 4.22 3.79 6.51 5.31 5.38 7.66

Balance Sheet View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 71 81 88 681 436 472 488 447 595
Non Curr. Liab. 74 94 83 63 176 185 325 336 409
Curr. Liab. 111 104 117 118 125 14 17 19 23
Minority Int.
Equity & Liab. 257 279 288 861 737 670 830 802 1,027
Non Curr. Assets 189 196 196 758 600 652 828 797 975
Curr. Assets 67 82 92 104 137 19 2 5 52
Misc. Exp. not W/O
Total Assets 257 279 288 861 737 670 830 802 1,027

Profit Loss View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 40 40 40 46 53 60 63 63 63
Other Income 2 1 2 1 2 11 3 4 7
Total Income 42 41 42 47 56 71 66 67 71
Total Expenditure -5 -5 -9 -4 -5 -4 -5 -5 -6
PBIDT 38 37 32 43 51 68 61 61 65
Interest -12 -9 -8 -5 -3 -6 -2 -2 -7
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -2
Taxation -8 -9 -8 -13 -16 -15 -18 -14 -15
Exceptional Items 29
PAT 17 18 15 24 30 46 40 44 70

Cash Flow View Details

Particulars 9 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 20 32 26 65 25 48 42 46 40
Cash Fr. Inv. -3 1 0 -5 -6 -35 -43 -7 -68
Cash Fr. Finan. -20 -33 -26 -62 -5 -10 -16 -40 28
Net Change -2 0 0 -2 14 2 -17 0 0
Cash & Cash Eqvt 2 2 3 1 15 17 1 0 0

Shareholding Pattern View Details

9 Qtrs 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%)
Promoter 69.82 69.82 69.82 69.82 69.82 69.82 69.82 69.82 69.82
Public 30.18 30.18 30.18 30.18 30.18 30.18 30.18 30.18 30.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Thu, 05 Aug 2021
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 33 and Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure requirements) Regulations 2015 please find enclosed herewith copy of notice published in the following newspaper:

Wed, 04 Aug 2021
Board Meeting Outcome for Outcome Of The Board Meeting Held On 4Th August 2021
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing regulations) we wish to inform you that Board of Directors of the Company in their meeting held on 4th August 2021 have inter alia approved the Unaudited Financial Results for the quarter ended June 30 2021 as recommended by the Audit Committee
Wed, 04 Aug 2021
Outcome Of The Board Meeting Held On 4Th August 2021
In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing regulations) we wish to inform you that Board of Directors of the Company in their meeting held on 4th August 2021 have inter alia approved the Unaudited Financial Results for the quarter ended June 30 2021 as recommended by the Audit Committee.

Technical Scans View Details

Thu, 05 Aug 2021
Close Crossing Last Week Low Close Crossing Last Week Low
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Syngene International Ltd. 24,775.24 618.15 -0.4%
Quess Corp Ltd. 12,588.67 852.00 -4.2%
RattanIndia Enterprises Ltd. 7,865.11 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. 7,564.00 288.65 +5.3%
SIS Ltd. 6,938.39 472.75 -2.9%
TeamLease Services Ltd. 6,792.55 3,973.00 +0.3%
Just Dial Ltd. 6,035.66 967.75 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 58.40 618.15 -0.4%
Quess Corp Ltd. Consolidated 2021-03 217.51 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2021-03 0.00 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-06 0.00 288.65 +5.3%
SIS Ltd. Consolidated 2021-06 18.78 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2021-06 77.65 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2021-06 47.41 967.75 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Syngene International Ltd. Consolidated 2021-06 8.78 618.15 -0.4%
Quess Corp Ltd. Consolidated 2021-03 5.37 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2021-03 92.70 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2021-06 -32.72 288.65 +5.3%
SIS Ltd. Consolidated 2021-06 3.89 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2021-06 10.01 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2021-06 4.79 967.75 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Syngene International Ltd. Consolidated 2021-03 0.28 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 0.51 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.00 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -3.67 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 0.74 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 0.14 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 0.00 967.75 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 16.59 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 -16.80 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.24 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -225.08 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 23.02 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 6.75 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 24.85 967.75 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 15.40 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 -5.79 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 0.63 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -178.22 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 21.05 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 16.25 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 31.48 967.75 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 2,184.30 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 10,991.48 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 76.81 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 9,127.30 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 5,200.72 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 953.11 967.75 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Syngene International Ltd. Consolidated 2021-03 404.90 618.15 -0.4%
Quess Corp Ltd. Consolidated 2020-03 -418.05 852.00 -4.2%
RattanIndia Enterprises Ltd. Consolidated 2020-03 -0.38 56.90 -4.9%
Sun Pharma Advanced Research Company Ltd. Standalone 2020-03 -312.40 288.65 +5.3%
SIS Ltd. Consolidated 2021-03 366.66 472.75 -2.9%
TeamLease Services Ltd. Consolidated 2020-03 37.06 3,973.00 +0.3%
Just Dial Ltd. Consolidated 2020-03 272.31 967.75 +0.1%